IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VIGANO', OTTAVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.907
EU - Europa 1.422
AS - Asia 1.261
Continente sconosciuto - Info sul continente non disponibili 200
SA - Sud America 193
AF - Africa 38
OC - Oceania 7
Totale 5.028
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.818
SG - Singapore 380
GB - Regno Unito 377
CN - Cina 348
IT - Italia 286
DE - Germania 174
BR - Brasile 148
SE - Svezia 145
BD - Bangladesh 139
RU - Federazione Russa 98
HK - Hong Kong 94
CA - Canada 73
FR - Francia 71
VN - Vietnam 65
NL - Olanda 62
IN - India 53
UA - Ucraina 51
TR - Turchia 46
FI - Finlandia 42
IE - Irlanda 38
KR - Corea 34
EU - Europa 26
JP - Giappone 23
ID - Indonesia 22
BE - Belgio 19
CI - Costa d'Avorio 15
CO - Colombia 14
GR - Grecia 10
ZA - Sudafrica 8
AR - Argentina 7
DK - Danimarca 7
ES - Italia 7
PL - Polonia 7
VE - Venezuela 7
AT - Austria 6
AU - Australia 6
CL - Cile 5
MX - Messico 5
TH - Thailandia 5
IL - Israele 4
IQ - Iraq 4
JO - Giordania 4
MA - Marocco 4
PK - Pakistan 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EC - Ecuador 3
OM - Oman 3
PE - Perù 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GT - Guatemala 2
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SV - El Salvador 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
JM - Giamaica 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
MW - Malawi 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 4.855
Salva come PNG Salva come JPEG
Città #
Southend 326
Ashburn 245
Singapore 220
Chandler 144
San Jose 88
Hong Kong 84
Milan 84
Fairfield 79
Beijing 73
Santa Clara 70
Dallas 68
Ann Arbor 67
Council Bluffs 67
Woodbridge 62
Seattle 56
Wilmington 51
Houston 48
Los Angeles 48
Princeton 43
Dearborn 38
Dublin 38
New York 35
Toronto 33
Cambridge 28
Jacksonville 28
Boardman 26
Buffalo 26
Munich 26
Frankfurt am Main 24
Redmond 24
Ho Chi Minh City 23
Montreal 20
Brussels 19
Helsinki 19
Tokyo 19
Jakarta 18
Lauterbourg 18
Hefei 17
Rome 17
Bengaluru 16
Nanjing 16
Somerville 16
São Paulo 15
Columbus 14
Mountain View 14
Phoenix 14
Sakarya 14
Shanghai 14
Abidjan 12
Guangzhou 12
Hanoi 12
Naples 12
Andover 11
Bogotá 11
Cangzhou 11
Des Moines 11
Moscow 11
The Dalles 11
Tianjin 11
Turin 11
Athens 10
Redwood City 10
Seoul 10
Florence 9
Grafing 8
Kent 8
Orem 8
Serra 8
Atlanta 7
Cagliari 7
Jinan 7
Warsaw 7
Chicago 6
Hebei 6
Margão 6
Nürnberg 6
Padova 6
Porto Alegre 6
Silver Spring 6
Belo Horizonte 5
Changsha 5
London 5
Mumbai 5
Nanchang 5
Quanzhou 5
San Diego 5
San Francisco 5
Shenyang 5
Turku 5
Wuhan 5
Yubileyny 5
Amman 4
Bari 4
Berlin 4
Boston 4
Brasília 4
Catania 4
Eitensheim 4
Fuzhou 4
Haiphong 4
Totale 2.925
Salva come PNG Salva come JPEG
Nome #
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir 352
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens 344
Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results 322
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV : experience in a pediatric population 310
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates 305
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation 296
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses 285
Efficacia di Caspofungin nella candidosi esofagea HIV-correlata multifarmacoresistente 262
Unusual codon 69 insertions : influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility 258
Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral- experienced HIV-1-infected subjects treated with tenofovir combination therapy [2] 241
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 232
Female gender is associated with long COVID syndrome : a prospective cohort study 219
Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an HIV-infected patient failing all four classes of antiretroviral drugs 218
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatmentefficacy in UGT1A1*28 polymorphism carriers 214
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19 211
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients : a randomized, controlled, pilot study (the REYAGEN study) 180
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients 172
Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice 158
New HIV protease inhibitors for drug-resistant viruses 157
Haemoptysis and fever in a young refugee from Somalia 150
Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin 139
null 3
Totale 5.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022232 0 9 11 9 14 11 20 22 50 26 11 49
2022/2023409 41 46 39 53 33 86 6 33 51 2 15 4
2023/2024232 13 20 16 29 38 13 17 14 3 11 19 39
2024/2025750 18 54 12 93 70 36 67 58 52 73 70 147
2025/20261.539 161 126 144 96 113 80 171 51 134 124 228 111
2026/2027151 88 63 0 0 0 0 0 0 0 0 0 0
Totale 5.028